Society Of Radiopharmaceutical Sciences
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2010 | 94,918 | 188,104 | −93,186 | 5.2 | — |
| 2011 | 157,183 | 113,105 | 44,078 | 13.3 | — |
| 2012 | 106,285 | 84,147 | 22,138 | 21.1 | — |
| 2013 | 82,066 | 103,173 | −21,107 | 14.8 | — |
| 2014 | 74,400 | 86,022 | −11,622 | 16.1 | — |
| 2015 | 235,641 | 123,146 | 112,495 | 22.2 | 0% |
| 2016 | 59,267 | 77,440 | −18,173 | 32.5 | 0% |
| 2017 | 161,512 | 128,887 | 32,625 | 22.5 | 0% |
| 2018 | 316,870 | 185,737 | 131,133 | 24.1 | 0% |
| 2019 | 666,837 | 596,033 | 70,804 | 8.9 | 0% |
| 2020 | 70,092 | 100,902 | −30,810 | 49.2 | 0% |
| 2021 | 206,794 | 264,795 | −58,001 | 16.1 | 0% |
| 2022 | 749,461 | 625,697 | 123,764 | 9.2 | 0% |
| 2023 | 791,427 | 683,673 | 107,754 | 10.3 | 0% |
In its most recent public year (2023), this organization brought in $107,754 more than it spent. Its reserves stood at about 10.3 months of spending, up from 5.2 in 2010. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Society Of Radiopharmaceutical Sciences's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works